The emerging treatment of the medication represents a significant development in the handling of type 2 diabetes. Unlike existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide411890.amoblog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-64142043